نتائج البحث - "Shimokawa, Mototsugu"

1

دورية أكاديمية

Efficacy of immune checkpoint inhibitors in younger patients with non-small cell lung cancer.

المؤلفون: Takamori, Shinkichi^1,2 (AUTHOR), Shimokawa, Mototsugu³ (AUTHOR), Komiya, Takefumi⁴ (AUTHOR) tkomiya@pennstatehealth.psu.edu

المصدر: Journal of Cancer Research & Clinical Oncology. Nov2023, Vol. 149 Issue 14, p13175-13184. 10p.

مصطلحات موضوعية: *NON-small-cell lung carcinoma, *IMMUNE checkpoint inhibitors, *IPILIMUMAB, *PROPENSITY score matching

النص الكامل

2

دورية أكاديمية

Impact of the pretreatment prognostic nutritional index on the survival after first‐line immunotherapy in non‐small‐cell lung cancer patients.

المصدر: Cancer Medicine; Jul2023, Vol. 12 Issue 13, p14327-14336, 10p

مصطلحات موضوعية: NON-small-cell lung carcinoma, CANCER patients, IMMUNE checkpoint inhibitors, LYMPHOCYTE count, IMMUNOTHERAPY

النص الكامل

3

دورية أكاديمية

A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation-positive NSCLC in whom systemic disease (T790M-negative) progressed after treatment with first- or second-generation EGFR TKIs and platinum-based chemotherapy

المؤلفون: Takeda, Masayuki^1,2 (AUTHOR) takeda-m@naramed-u.ac.jp, Shimokawa, Mototsugu³ (AUTHOR), Nakamura, Atsushi⁴ (AUTHOR), Nosaki, Kaname⁵ (AUTHOR), Watanabe, Yasutaka⁶ (AUTHOR), Kato, Terufumi⁷ (AUTHOR), Hayakawa, Daisuke⁸ (AUTHOR), Tanaka, Hiroshi⁹ (AUTHOR), Takahashi, Toshiaki¹⁰ (AUTHOR), Oki, Masahide¹¹ (AUTHOR), Tachihara, Motoko¹² (AUTHOR), Fujimoto, Daichi¹³ (AUTHOR), Hayashi, Hidetoshi¹ (AUTHOR), Yamaguchi, Kakuhiro¹⁴ (AUTHOR), Yamamoto, Shoichiro¹⁵ (AUTHOR), Iwama, Eiji¹⁶ (AUTHOR), Azuma, Koichi¹⁷ (AUTHOR), Hasegawa, Kazuo¹⁸ (AUTHOR), Yamamoto, Nobuyuki¹³ (AUTHOR), Nakagawa, Kazuhiko¹ (AUTHOR)

المصدر: Lung Cancer (01695002). Mar2023, Vol. 177, p44-50. 7p.

مصطلحات موضوعية: *EPIDERMAL growth factor receptors, *OSIMERTINIB, *NON-small-cell lung carcinoma, *PROTEIN-tyrosine kinase inhibitors

مصطلحات جغرافية: JAPAN

4

دورية أكاديمية

Survival benefit of using pemetrexed for EGFR mutation-positive advanced non-small-cell lung cancer in a randomized phase III study comparing gefitinib to cisplatin plus docetaxel (WJTOG3405).

المؤلفون: Haratake, Naoki^1,2 (AUTHOR), Shimokawa, Mototsugu³ (AUTHOR), Seto, Takashi² (AUTHOR) setocruise@gmail.com, Yoshioka, Hiroshige⁴ (AUTHOR), Yamamoto, Nobuyuki⁵ (AUTHOR), Nakagawa, Kazuhiko⁶ (AUTHOR), Mitsudomi, Tetsuya⁷ (AUTHOR)

المصدر: International Journal of Clinical Oncology. Sep2022, Vol. 27 Issue 9, p1404-1412. 9p.

مصطلحات موضوعية: *NON-small-cell lung carcinoma, *PEMETREXED, *EPIDERMAL growth factor receptors, *CLINICAL trials, *DOCETAXEL

5

دورية أكاديمية

Combination Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients with NSCLC Receiving Carboplatin-Based Chemotherapy.

المؤلفون: Shimokawa, Mototsugu, Haratake, Naoki, Takada, Kazuki, Toyokawa, Gouji, Takamori, Shinkichi, Mizuki, Fumitaka, Takenaka, Tomoyoshi, Hayashi, Toshinobu

المصدر: Cancer Management & Research; Sep2022, Vol. 14, p2673-2680, 8p

مصطلحات موضوعية: NON-small-cell lung carcinoma, NAUSEA, MOTION sickness, ANTIEMETICS, CHEMOTHERAPY complications

مصطلحات جغرافية: JAPAN

النص الكامل

6

دورية أكاديمية

Association between sex and outcomes in patients with non-small-cell lung cancer receiving combination chemoimmunotherapy as a first-line therapy: a systematic review and meta-analysis of randomized clinical trials.

المؤلفون: Takada, Kazuki, Shimokawa, Mototsugu, Mizuki, Fumitaka, Takamori, Shinkichi, Takenaka, Tomoyoshi, Miura, Naoko, Shikada, Yasunori, Yoshizumi, Tomoharu

المصدر: European Journal of Medical Research; 8/23/2022, Vol. 27 Issue 1, p1-9, 9p

مصطلحات موضوعية: IMMUNOTHERAPY, NON-small-cell lung carcinoma, CLINICAL trials, IMMUNE checkpoint inhibitors, TREATMENT effectiveness, PATIENTS

النص الكامل

7

دورية أكاديمية

Corrigendum to "A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation–positive NSCLC in whom systemic disease (T790M-negative) progressed after treatment with first- or second-generation EGFR TKI and platinum-based chemotherapy" [Lung Cancer 177 (2023) 44–50]

المؤلفون: Takeda, Masayuki^1,2 (AUTHOR) takeda-m@naramed-u.ac.jp, Shimokawa, Mototsugu³ (AUTHOR), Nakamura, Atsushi⁴ (AUTHOR), Nosaki, Kaname⁵ (AUTHOR), Watanabe, Yasutaka⁶ (AUTHOR), Kato, Terufumi⁷ (AUTHOR), Hayakawa, Daisuke⁸ (AUTHOR), Tanaka, Hiroshi⁹ (AUTHOR), Takahashi, Toshiaki¹⁰ (AUTHOR), Oki, Masahide¹¹ (AUTHOR), Tachihara, Motoko¹² (AUTHOR), Fujimoto, Daichi¹³ (AUTHOR), Hayashi, Hidetoshi¹ (AUTHOR), Yamaguchi, Kakuhiro¹⁴ (AUTHOR), Yamamoto, Shoichiro¹⁵ (AUTHOR), Iwama, Eiji¹⁶ (AUTHOR), Azuma, Koichi¹⁷ (AUTHOR), Hasegawa, Kazuo¹⁸ (AUTHOR), Yamamoto, Nobuyuki¹³ (AUTHOR), Nakagawa, Kazuhiko¹ (AUTHOR)

المصدر: Lung Cancer (01695002). Jul2024, Vol. 193, pN.PAG-N.PAG. 1p.

مصطلحات موضوعية: *EPIDERMAL growth factor receptors, *OSIMERTINIB, *NON-small-cell lung carcinoma, *THERAPEUTICS

8

دورية أكاديمية

A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study.

المؤلفون: Takada, Kazuki¹ (AUTHOR) k_takada@surg2.med.kyushu-u.ac.jp, Shimokawa, Mototsugu^2,3 (AUTHOR), Takamori, Shinkichi⁴ (AUTHOR) takamori@surg2.med.kyushu-u.ac.jp, Shimamatsu, Shinichiro¹ (AUTHOR), Hirai, Fumihiko¹ (AUTHOR), Tagawa, Tetsuzo⁵ (AUTHOR), Okamoto, Tatsuro⁴ (AUTHOR), Hamatake, Motoharu¹ (AUTHOR), Tsuchiya-Kawano, Yuko⁶ (AUTHOR), Otsubo, Kohei⁶ (AUTHOR), Inoue, Koji⁶ (AUTHOR), Yoneshima, Yasuto⁷ (AUTHOR), Tanaka, Kentaro⁷ (AUTHOR), Okamoto, Isamu⁷ (AUTHOR), Nakanishi, Yoichi⁶ (AUTHOR), Mori, Masaki⁵ (AUTHOR)

المصدر: BMC Cancer. 5/6/2022, Vol. 22 Issue 1, p1-10. 10p.

مصطلحات موضوعية: *NON-small-cell lung carcinoma, *STATINS (Cardiovascular agents), *CANCER prognosis, *PROGRESSION-free survival, *TREATMENT effectiveness, *DYSLIPIDEMIA

مصطلحات جغرافية: JAPAN

النص الكامل

9

دورية أكاديمية

The clinical impact of concomitant medication use on the outcome of postoperative recurrent non-small-cell lung cancer in patients receiving immune checkpoint inhibitors.

المؤلفون: Takada, Kazuki¹ (AUTHOR) takadakazuki1077@gmail.com, Shimokawa, Mototsugu^2,3 (AUTHOR), Takamori, Shinkichi⁴ (AUTHOR), Shimamatsu, Shinichiro¹ (AUTHOR), Hirai, Fumihiko¹ (AUTHOR), Ono, Yuki⁵ (AUTHOR), Tagawa, Tetsuzo⁵ (AUTHOR), Okamoto, Tatsuro⁴ (AUTHOR), Hamatake, Motoharu¹ (AUTHOR), Okamoto, Isamu⁶ (AUTHOR), Mori, Masaki⁵ (AUTHOR)

المصدر: PLoS ONE. 2/7/2022, Vol. 17 Issue 2, p1-11. 11p.

مصطلحات موضوعية: *NON-small-cell lung carcinoma, *IMMUNE checkpoint inhibitors, *TREATMENT effectiveness, *LOGISTIC regression analysis, *DRUGS

مصطلحات جغرافية: JAPAN

النص الكامل

10

دورية أكاديمية

Rationale and Design for a Multicenter, Phase II Study of Durvalumab Plus Concurrent Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Study (WJOG11619L).

المؤلفون: Tachihara, Motoko, Tsujino, Kayoko, Ishihara, Takeaki, Hayashi, Hidetoshi, Sato, Yuki, Kurata, Takayasu, Sugawara, Shunichi, Okamoto, Isamu, Teraoka, Shunsuke, Azuma, Koichi, Daga, Haruko, Yamaguchi, Masafumi, Kodaira, Takeshi, Satouchi, Miyako, Shimokawa, Mototsugu, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko

المصدر: Cancer Management & Research; Dec2021, Vol. 13, p9167-9173, 7p

مصطلحات موضوعية: NON-small-cell lung carcinoma, RADIOTHERAPY, PROGRESSION-free survival, OVERALL survival, CELL death

الشركة/الكيان: WORLD Health Organization

النص الكامل

تنقيح النتائج